- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00444899
Clinical and Economic Benefits of Cardiovascular Risk Management by a Dietician in Type 2 Diabetes Patients (GRC)
Clinical and Economic Benefits of Cardiovascular Risk Management by a Dietician in Diabetic Patients
Worldwide, health systems and practitioners are facing obesity epidemics. High blood pressure, dyslipidemia and diabetes prevalence will explode during the 21st century.
The two main objectives of this 2-year controlled prospective study are:
- to demonstrate that, for patients with high blood pressure, diabetes and dyslipidemia, dietician conducted survey and management in combination with annual endocrinologist follow-up enable both attainment and maintenance of recommended blood pressure, glycemic and lipid goals, as well as smoking cessation;
- to demonstrate that dietician management is more cost effective than conventional care provided by general practitioners and endocrinologists.
Results are expected to show significantly different cardiovascular risk profiles (BMI and waist circumference, systolic and diastolic blood pressure, LDL-C, triglycerides and Total cholesterol/HDL ratio, HbA1c, smoking) between baseline and after 2 years follow-up. Sample size was determined in order to show statistically significant differences between the two groups.
Results will document for the benefit of care givers, health economists and policy makers alike an innovative and integrated model of care which is expected to be effective at the patient level as well as cost effective with respect to the increasing financial burden of diabetes on the health system.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Sherbrooke, Quebec, Canada, J1H 5N4
- Centre de recherche clinique Etienne-Le Bel du CHUS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- HbA1c > 7%
- More than 2 follow-up visits
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intensive treatment
Submitted to an intensive follow-up by the dietician.
|
Subjects will be followed by the dietician in combination with his/her endocrinologist.
Diet, physical activity, smoking cessation and drug prescriptions will be used to treat subjects.
|
Active Comparator: Usual treatment
Subjects will remain under the care of their endocrinologist and/or general practitioner.
|
Subject will continue to be followed by their endocrinologist and general practitioner as they already do.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Lipid profile
Time Frame: 36 months
|
36 months
|
Blood pressure
Time Frame: 36 months
|
36 months
|
HbA1c
Time Frame: 36 months
|
36 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Patrice Perron, MD, MSc, Université de Sherbrooke
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NRA3840020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Study Data/Documents
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Eledon PharmaceuticalsWithdrawnBrittle Type 1 Diabetes MellitusUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Rabin Medical CenterDreaMed DiabetesTerminated
Clinical Trials on Intensive treatment
-
Austin Speech LabsUnknownAphasia | LanguageUnited States
-
The University of Hong KongNot yet recruitingStroke | Small Vessel Cerebrovascular Disease
-
VA Office of Research and DevelopmentCompletedStress Disorders, Post-TraumaticUnited States
-
Gruppo Italiano per la Valutazione degli Interventi...Not yet recruitingCentral Nervous System Diseases | Cardiac Arrest | Post-Anoxic Coma
-
Gruppo Italiano per la Valutazione degli Interventi...Medical University of Warsaw; European Commission; Semmelweis University; Ben-Gurion... and other collaboratorsCompletedBrain Injuries, TraumaticItaly
-
University College, LondonCompletedPeriodontitis | Intimal Medial Thickness of Internal Carotid ArteryUnited Kingdom
-
Ospedale Generale Di Zona Moriggia-PelasciniCompletedParkinson Disease and Pisa SyndromeItaly
-
Mayo ClinicUniversity of South Florida; Fordham UniversityCompletedObsessive Compulsive DisorderUnited States
-
University Hospital of CologneAlbert Einstein College of Medicine; Monash University; The Alfred; Johann Wolfgang... and other collaboratorsNot yet recruiting
-
Susanne WalitzaRecruitingObsessive-Compulsive DisorderSwitzerland